Upgrade to SI Premium - Free Trial

Guardant Health (GH) PT Raised to $200 at Bernstein SocGen

July 2, 2026 11:41 AM
Bernstein SocGen Group analyst Eve Burstein raised the price target on Guardant Health (NASDAQ: GH) to $200.00 (from $175.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change